Related Experiment Videos
A cofactor approach to copper-dependent catalytic antibodies
Kenneth M Nicholas1, Paul Wentworth, Curtis W Harwig
1Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK 73019, USA. kmnicholas@chemdept.chem.ou.edu
Summary
Researchers developed a semisynthetic catalytic metalloprotein by incorporating a bis-imidazole cofactor into an aldolase antibody. This antibody-metal complex efficiently catalyzes ester hydrolysis, demonstrating a significant catalytic advantage.
Area of Science:
- Biochemistry
- Catalysis
- Protein Engineering
Background:
- Antibodies can be engineered as catalysts.
- Metal-binding cofactors can be incorporated into antibody active sites.
- Aldolase antibody 38C2 has a suitable active site for modification.
Purpose of the Study:
- To create a semisynthetic catalytic metalloprotein using an antibody scaffold.
- To incorporate a bis-imidazole metal-binding cofactor into aldolase antibody 38C2.
- To evaluate the catalytic activity of the resulting conjugate.
Main Methods:
- Covalent modification of antibody 38C2 Lys(H93) residue using a bis-imidazole anhydride.
- Preparation of the copper(II)-bis-imidazole antibody conjugate (38C2-5-Cu).
- Assay of catalytic activity for picolinate ester hydrolysis.
Main Results:
- Bis-imidazole anhydride effectively derivatized the antibody.
- The 38C2-5-Cu conjugate catalyzed ester hydrolysis with Michaelis-Menten kinetics.
- A significant rate enhancement of 2.1 x 10^5 was observed compared to the uncatalyzed reaction.
- The antibody-bound cofactor showed a catalytic advantage over the free complex.
Conclusions:
- A strategy for creating semisynthetic catalytic metalloproteins was established.
- Antibody engineering can enhance the catalytic efficiency of metal cofactors.
- The antibody-metal conjugate is a potent catalyst for ester hydrolysis.